Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 30 clinical trials
Featured trial
Eltrombopag for People With Fanconi Anemia

Fanconi anemia is a genetic disease. Some people with it have reduced blood cell counts. This means their bone marrow no longer works properly. These people may need blood transfusions for anemia (low red blood cells) or low platelet counts or bleeding. Researchers want to see if a new drug …

fanconi's syndrome
fanconi's anemia
anemia studies
anemia
  • 91 views
  • 22 Dec, 2020
  • 1 location
Featured trial
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia

attacking the bone marrow. However, this treatment does not work in all people. Some people still have poor blood cell counts even after treatment. Eltrombopag is a drug designed to mimic a protein

myelodysplastic syndrome (mds)
anemia studies
anemia
aplastic anemia
myelodysplastic syndromes
  • 132 views
  • 22 Dec, 2020
  • 1 location
Featured trial
A Randomized Trial of Sirolimus (Rapamune) for Relapse Prevention in Patients with Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

Background: People with severe aplastic anemia (SAA) do not make enough red and white blood cells, and/or platelets. Their body's immune system stops the bone marrow from making these cells. The treatment cyclosporine leads to better blood counts. But when this treatment is stopped, the disease may return in 1 …

myelodysplastic syndrome (mds)
anemia studies
anemia
aplastic anemia
myelodysplastic syndromes
  • 61 views
  • 22 Dec, 2020
  • 1 location
None
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

This study is designed to evaluate the efficacy and safety of eltrombopag when added to r-ATG and CsA in treatment naive East-Asian adult and pediatric patients with SAA.

  • 0 views
  • 16 Oct, 2021
  • 14 locations
None
Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

dose. Diacerein is a slow-acting medicine of the class anthraquinone used to treat joint diseases such as osteoarthritis. We speculate that the addition of diacerein to eltrombopag may offer sensitizer

platelet count
eltrombopag
  • 1 views
  • 19 Jun, 2021
  • 1 location
None
Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

This multicenter randomized, open-label study aimed to compare the efficacy and safety of eltrombopag combining rituximab with eltrombopag in China adult ITP patients .This study was be

  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

transfusions regularly which are time consuming and can have significant side effects. The drug eltrombopag can increase red blood cells. Researchers want to see if it can help people with DBA and, if so, for

cell counts
  • 1 views
  • 05 Oct, 2021
  • 1 location
None
Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA

adding eltrombopag to standard immunosuppressive therapy

  • 39 views
  • 21 Mar, 2021
  • 1 location
None
Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

SSA is a combination of 3 drugs (Cyclosporine [CsA], Eltrombopag [EPAG], and horse anti-thymocyte globulin [h-ATG]). Researchers want to see if starting people at a lower dose of CsA with EPAG before

reticulocyte count
immunosuppressant
immunosuppression
blood test
platelet count
  • 1 views
  • 10 Oct, 2021
  • 1 location
None
Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

This is a prospective, open-label, randomized, two-arm clinical trial conducted to evaluate the safety and efficacy of romiplostim in comparison with eltrombopag in the treatment of

  • 0 views
  • 24 Jan, 2021
  • 1 location